Loading
ZB
Zymeworks BC Inc. Stock: price and insider trades · United States
Zymeworks BC Inc.: what insiders have been doing
Only a handful of insider records exist for Zymeworks BC Inc., the last one from 14 November 2022, too few to describe a trend. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€20,008
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2021FY ended December 2021 · cache
Income statement
Revenue23.8M
Net income-188.6M-794.0% margin
Last declaration on 14 November 2022
Declarations2 total
2,475 shares@ US$8.10100.0% of flowCommon StockSEC:0000899243-22-035785:1
5,885 shares0Common StockSEC:0000899243-22-035785:0
2 of 2 declarations
About Zymeworks BC Inc.
Zymeworks BC Inc. is a biopharmaceutical company focused on developing protein-based therapies for the treatment of cancer and other diseases. It is listed on NASDAQ under the ticker symbol ZYME.
